Rationally Designed, Synthetic Antibody Libraries and Uses Therefor
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 7 of these applications claim priority to application 60/993,785, filed Sep 14, 2007. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,008,568 | Rationally Designed, Synthetic Antibody Libraries and Uses Therefor In force · High confidence | Adimab, LLC | In force | High confidence | ||
| US 12,529,164 | Rationally Designed, Synthetic Antibody Libraries and Uses Therefor In force · Medium confidence | Adimab, LLC | In force | Medium confidence | ||
| US 11,008,383 | Rationally Designed, Synthetic Antibody Libraries and Uses Therefor In force · High confidence | Adimab, LLC | In force | High confidence | ||
| US 10,196,635 | Rationally Designed, Synthetic Antibody Libraries and Uses Therefor In force · Medium confidence | Adimab, LLC | In force | Medium confidence | ||
| US 8,691,730 | Rationally Designed, Synthetic Antibody Libraries and Uses Therefor In force · High confidence | Adimab, LLC | In force | High confidence | ||
| US 10,189,894 | Rationally Designed, Synthetic Antibody Libraries and Uses Therefor In force · High confidence | Adimab, LLC | In force | High confidence | ||
| US 8,877,688 | Rationally Designed, Synthetic Antibody Libraries and Uses Therefor In force · Medium confidence | Adimab, LLC | In force | Medium confidence | ||
| Application 17/229,484 | Rationally Designed, Synthetic Antibody Libraries and Uses Therefor Abandoned Abandoned Nov 23, 2021 | Adimab, LLC | Abandoned | Abandoned Nov 23, 2021 | ||
| Application 17/231,414 | Rationally Designed, Synthetic Antibody Libraries and Uses Therefor Abandoned Abandoned Nov 30, 2021 | Adimab, LLC | Abandoned | Abandoned Nov 30, 2021 | ||
| Application 17/532,287 | Rationally Designed, Synthetic Antibody Libraries and Uses Therefor Abandoned Abandoned Jul 6, 2022 | Adimab, LLC | Abandoned | Abandoned Jul 6, 2022 | ||
| 2 more patents in this group · Pro | ||||||
10 of 12 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 12.
7 of these are in force and held by Adimab, LLC.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.